【市場調査レポート】地図状萎縮治療のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Geographic Atrophy Treatment Market Insights, Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。地図状萎縮治療のグローバル市場インサイト・予測（～2028年） / Global Geographic Atrophy Treatment Market Insights, Forecast to 2028 / QY2207C3463資料のイメージです。

• レポートコード：QY2207C3463
• 出版社/出版日：QYResearch / 2022年7月11日
• レポート形態：英文、PDF、110ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症のパンデミックにより、世界の地図状萎縮治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に地図状萎縮治療の世界市場のxxx％を占める「後期（フェーズIII）治療」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国の地図状萎縮治療の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの地図状萎縮治療市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの地図状萎縮治療市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

地図状萎縮治療のグローバル主要メーカーには、Apellis Pharmaceuticals、IVERIC bio、Alkeus Pharmaceuticals、Hemera Biosciences、Allegro Ophthalmics、Stealth BioTherapeutics、Gyroscope Therapeutics、Regenerative Patch Technologies、Roche Holding AG、Gensight Biologics SA、NGM Biopharmaceuticals、AstraZeneca、Lineage Cell Therapeutics、Allerganなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

地図状萎縮治療市場は、種類と用途によって区分されます。世界の地図状萎縮治療市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
後期（フェーズIII）治療、フェーズII治療、フェーズI治療、前臨床段階治療

【用途別セグメント】
病院、クリニック

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 地図状萎縮治療製品概要
- 種類別市場（後期（フェーズIII）治療、フェーズII治療、フェーズI治療、前臨床段階治療）
- 用途別市場（病院、クリニック）
- 調査の目的
・エグゼクティブサマリー
- 世界の地図状萎縮治療販売量予測2017-2028
- 世界の地図状萎縮治療売上予測2017-2028
- 地図状萎縮治療の地域別販売量
- 地図状萎縮治療の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別地図状萎縮治療販売量
- 主要メーカー別地図状萎縮治療売上
- 主要メーカー別地図状萎縮治療価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（後期（フェーズIII）治療、フェーズII治療、フェーズI治療、前臨床段階治療）
- 地図状萎縮治療の種類別販売量
- 地図状萎縮治療の種類別売上
- 地図状萎縮治療の種類別価格
・用途別市場規模（病院、クリニック）
- 地図状萎縮治療の用途別販売量
- 地図状萎縮治療の用途別売上
- 地図状萎縮治療の用途別価格
・北米市場
- 北米の地図状萎縮治療市場規模（種類別、用途別）
- 主要国別の地図状萎縮治療市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの地図状萎縮治療市場規模（種類別、用途別）
- 主要国別の地図状萎縮治療市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の地図状萎縮治療市場規模（種類別、用途別）
- 主要国別の地図状萎縮治療市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の地図状萎縮治療市場規模（種類別、用途別）
- 主要国別の地図状萎縮治療市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの地図状萎縮治療市場規模（種類別、用途別）
- 主要国別の地図状萎縮治療市場規模（トルコ、サウジアラビア）
・企業情報
Apellis Pharmaceuticals、IVERIC bio、Alkeus Pharmaceuticals、Hemera Biosciences、Allegro Ophthalmics、Stealth BioTherapeutics、Gyroscope Therapeutics、Regenerative Patch Technologies、Roche Holding AG、Gensight Biologics SA、NGM Biopharmaceuticals、AstraZeneca、Lineage Cell Therapeutics、Allergan
・産業チェーン及び販売チャネル分析
- 地図状萎縮治療の産業チェーン分析
- 地図状萎縮治療の原材料
- 地図状萎縮治療の生産プロセス
- 地図状萎縮治療の販売及びマーケティング
- 地図状萎縮治療の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 地図状萎縮治療の産業動向
- 地図状萎縮治療のマーケットドライバー
- 地図状萎縮治療の課題
- 地図状萎縮治療の阻害要因
・主な調査結果

Geographic atrophy (GA) is an advanced form of age-related macular degeneration (AMD) that causes a continuous progressive degeneration of the macula. The condition is characterized by widespread atrophy of the outer retinal tissue, retinal pigment epithelium, and choriocapillaris. It typically starts in the perifoveal region and develops to the fovea over time and causing central scotomas and permanent vision loss. Various drugs and treatments are under evaluation.
Market Analysis and Insights: Global Geographic Atrophy Treatment Market
The global Geographic Atrophy Treatment market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Late-stage (Phase III) Treatment accounting for % of the Geographic Atrophy Treatment global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Geographic Atrophy Treatment market size is valued at US$ million in 2021, while the North America and Europe Geographic Atrophy Treatment are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Geographic Atrophy Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Geographic Atrophy Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Geographic Atrophy Treatment market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Geographic Atrophy Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Geographic Atrophy Treatment market.
Global Geographic Atrophy Treatment Scope and Market Size
Geographic Atrophy Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Geographic Atrophy Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Late-stage (Phase III) Treatment
Phase II Treatment
Phase I Treatment
Pre-Clinical Stage Treatment
Segment by Application
Hospital
Clinic
By Company
Apellis Pharmaceuticals
IVERIC bio
Alkeus Pharmaceuticals
Hemera Biosciences
Allegro Ophthalmics
Stealth BioTherapeutics
Gyroscope Therapeutics
Regenerative Patch Technologies
Roche Holding AG
Gensight Biologics SA
NGM Biopharmaceuticals
AstraZeneca
Lineage Cell Therapeutics
Allergan
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Geographic Atrophy Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Late-stage (Phase III) Treatment
1.2.3 Phase II Treatment
1.2.4 Phase I Treatment
1.2.5 Pre-Clinical Stage Treatment
1.3 Market by Application
1.3.1 Global Geographic Atrophy Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Geographic Atrophy Treatment Market Perspective (2017-2028)
2.2 Geographic Atrophy Treatment Growth Trends by Region
2.2.1 Geographic Atrophy Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Geographic Atrophy Treatment Historic Market Size by Region (2017-2022)
2.2.3 Geographic Atrophy Treatment Forecasted Market Size by Region (2023-2028)
2.3 Geographic Atrophy Treatment Market Dynamics
2.3.1 Geographic Atrophy Treatment Industry Trends
2.3.2 Geographic Atrophy Treatment Market Drivers
2.3.3 Geographic Atrophy Treatment Market Challenges
2.3.4 Geographic Atrophy Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Geographic Atrophy Treatment Players by Revenue
3.1.1 Global Top Geographic Atrophy Treatment Players by Revenue (2017-2022)
3.1.2 Global Geographic Atrophy Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Geographic Atrophy Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Geographic Atrophy Treatment Revenue
3.4 Global Geographic Atrophy Treatment Market Concentration Ratio
3.4.1 Global Geographic Atrophy Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Geographic Atrophy Treatment Revenue in 2021
3.5 Geographic Atrophy Treatment Key Players Head office and Area Served
3.6 Key Players Geographic Atrophy Treatment Product Solution and Service
3.7 Date of Enter into Geographic Atrophy Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Geographic Atrophy Treatment Breakdown Data by Type
4.1 Global Geographic Atrophy Treatment Historic Market Size by Type (2017-2022)
4.2 Global Geographic Atrophy Treatment Forecasted Market Size by Type (2023-2028)
5 Geographic Atrophy Treatment Breakdown Data by Application
5.1 Global Geographic Atrophy Treatment Historic Market Size by Application (2017-2022)
5.2 Global Geographic Atrophy Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Geographic Atrophy Treatment Market Size (2017-2028)
6.2 North America Geographic Atrophy Treatment Market Size by Type
6.2.1 North America Geographic Atrophy Treatment Market Size by Type (2017-2022)
6.2.2 North America Geographic Atrophy Treatment Market Size by Type (2023-2028)
6.2.3 North America Geographic Atrophy Treatment Market Share by Type (2017-2028)
6.3 North America Geographic Atrophy Treatment Market Size by Application
6.3.1 North America Geographic Atrophy Treatment Market Size by Application (2017-2022)
6.3.2 North America Geographic Atrophy Treatment Market Size by Application (2023-2028)
6.3.3 North America Geographic Atrophy Treatment Market Share by Application (2017-2028)
6.4 North America Geographic Atrophy Treatment Market Size by Country
6.4.1 North America Geographic Atrophy Treatment Market Size by Country (2017-2022)
6.4.2 North America Geographic Atrophy Treatment Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Geographic Atrophy Treatment Market Size (2017-2028)
7.2 Europe Geographic Atrophy Treatment Market Size by Type
7.2.1 Europe Geographic Atrophy Treatment Market Size by Type (2017-2022)
7.2.2 Europe Geographic Atrophy Treatment Market Size by Type (2023-2028)
7.2.3 Europe Geographic Atrophy Treatment Market Share by Type (2017-2028)
7.3 Europe Geographic Atrophy Treatment Market Size by Application
7.3.1 Europe Geographic Atrophy Treatment Market Size by Application (2017-2022)
7.3.2 Europe Geographic Atrophy Treatment Market Size by Application (2023-2028)
7.3.3 Europe Geographic Atrophy Treatment Market Share by Application (2017-2028)
7.4 Europe Geographic Atrophy Treatment Market Size by Country
7.4.1 Europe Geographic Atrophy Treatment Market Size by Country (2017-2022)
7.4.2 Europe Geographic Atrophy Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Geographic Atrophy Treatment Market Size (2017-2028)
8.2 Asia-Pacific Geographic Atrophy Treatment Market Size by Type
8.2.1 Asia-Pacific Geographic Atrophy Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Geographic Atrophy Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Geographic Atrophy Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Geographic Atrophy Treatment Market Size by Application
8.3.1 Asia-Pacific Geographic Atrophy Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Geographic Atrophy Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Geographic Atrophy Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Geographic Atrophy Treatment Market Size by Region
8.4.1 Asia-Pacific Geographic Atrophy Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Geographic Atrophy Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Geographic Atrophy Treatment Market Size (2017-2028)
9.2 Latin America Geographic Atrophy Treatment Market Size by Type
9.2.1 Latin America Geographic Atrophy Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Geographic Atrophy Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Geographic Atrophy Treatment Market Share by Type (2017-2028)
9.3 Latin America Geographic Atrophy Treatment Market Size by Application
9.3.1 Latin America Geographic Atrophy Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Geographic Atrophy Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Geographic Atrophy Treatment Market Share by Application (2017-2028)
9.4 Latin America Geographic Atrophy Treatment Market Size by Country
9.4.1 Latin America Geographic Atrophy Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Geographic Atrophy Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Geographic Atrophy Treatment Market Size (2017-2028)
10.2 Middle East & Africa Geographic Atrophy Treatment Market Size by Type
10.2.1 Middle East & Africa Geographic Atrophy Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Geographic Atrophy Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Geographic Atrophy Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Geographic Atrophy Treatment Market Size by Application
10.3.1 Middle East & Africa Geographic Atrophy Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Geographic Atrophy Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Geographic Atrophy Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Geographic Atrophy Treatment Market Size by Country
10.4.1 Middle East & Africa Geographic Atrophy Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Geographic Atrophy Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Apellis Pharmaceuticals
11.1.1 Apellis Pharmaceuticals Company Details
11.1.2 Apellis Pharmaceuticals Business Overview
11.1.3 Apellis Pharmaceuticals Geographic Atrophy Treatment Introduction
11.1.4 Apellis Pharmaceuticals Revenue in Geographic Atrophy Treatment Business (2017-2022)
11.1.5 Apellis Pharmaceuticals Recent Developments
11.2 IVERIC bio
11.2.1 IVERIC bio Company Details
11.2.2 IVERIC bio Business Overview
11.2.3 IVERIC bio Geographic Atrophy Treatment Introduction
11.2.4 IVERIC bio Revenue in Geographic Atrophy Treatment Business (2017-2022)
11.2.5 IVERIC bio Recent Developments
11.3 Alkeus Pharmaceuticals
11.3.1 Alkeus Pharmaceuticals Company Details
11.3.2 Alkeus Pharmaceuticals Business Overview
11.3.3 Alkeus Pharmaceuticals Geographic Atrophy Treatment Introduction
11.3.4 Alkeus Pharmaceuticals Revenue in Geographic Atrophy Treatment Business (2017-2022)
11.3.5 Alkeus Pharmaceuticals Recent Developments
11.4 Hemera Biosciences
11.4.1 Hemera Biosciences Company Details
11.4.2 Hemera Biosciences Business Overview
11.4.3 Hemera Biosciences Geographic Atrophy Treatment Introduction
11.4.4 Hemera Biosciences Revenue in Geographic Atrophy Treatment Business (2017-2022)
11.4.5 Hemera Biosciences Recent Developments
11.5 Allegro Ophthalmics
11.5.1 Allegro Ophthalmics Company Details
11.5.2 Allegro Ophthalmics Business Overview
11.5.3 Allegro Ophthalmics Geographic Atrophy Treatment Introduction
11.5.4 Allegro Ophthalmics Revenue in Geographic Atrophy Treatment Business (2017-2022)
11.5.5 Allegro Ophthalmics Recent Developments
11.6 Stealth BioTherapeutics
11.6.1 Stealth BioTherapeutics Company Details
11.6.2 Stealth BioTherapeutics Business Overview
11.6.3 Stealth BioTherapeutics Geographic Atrophy Treatment Introduction
11.6.4 Stealth BioTherapeutics Revenue in Geographic Atrophy Treatment Business (2017-2022)
11.6.5 Stealth BioTherapeutics Recent Developments
11.7 Gyroscope Therapeutics
11.7.1 Gyroscope Therapeutics Company Details
11.7.2 Gyroscope Therapeutics Business Overview
11.7.3 Gyroscope Therapeutics Geographic Atrophy Treatment Introduction
11.7.4 Gyroscope Therapeutics Revenue in Geographic Atrophy Treatment Business (2017-2022)
11.7.5 Gyroscope Therapeutics Recent Developments
11.8 Regenerative Patch Technologies
11.8.1 Regenerative Patch Technologies Company Details
11.8.2 Regenerative Patch Technologies Business Overview
11.8.3 Regenerative Patch Technologies Geographic Atrophy Treatment Introduction
11.8.4 Regenerative Patch Technologies Revenue in Geographic Atrophy Treatment Business (2017-2022)
11.8.5 Regenerative Patch Technologies Recent Developments
11.9 Roche Holding AG
11.9.1 Roche Holding AG Company Details
11.9.2 Roche Holding AG Business Overview
11.9.3 Roche Holding AG Geographic Atrophy Treatment Introduction
11.9.4 Roche Holding AG Revenue in Geographic Atrophy Treatment Business (2017-2022)
11.9.5 Roche Holding AG Recent Developments
11.10 Gensight Biologics SA
11.10.1 Gensight Biologics SA Company Details
11.10.2 Gensight Biologics SA Business Overview
11.10.3 Gensight Biologics SA Geographic Atrophy Treatment Introduction
11.10.4 Gensight Biologics SA Revenue in Geographic Atrophy Treatment Business (2017-2022)
11.10.5 Gensight Biologics SA Recent Developments
11.11 NGM Biopharmaceuticals
11.11.1 NGM Biopharmaceuticals Company Details
11.11.2 NGM Biopharmaceuticals Business Overview
11.11.3 NGM Biopharmaceuticals Geographic Atrophy Treatment Introduction
11.11.4 NGM Biopharmaceuticals Revenue in Geographic Atrophy Treatment Business (2017-2022)
11.11.5 NGM Biopharmaceuticals Recent Developments
11.12 AstraZeneca
11.12.1 AstraZeneca Company Details
11.12.2 AstraZeneca Business Overview
11.12.3 AstraZeneca Geographic Atrophy Treatment Introduction
11.12.4 AstraZeneca Revenue in Geographic Atrophy Treatment Business (2017-2022)
11.12.5 AstraZeneca Recent Developments
11.13 Lineage Cell Therapeutics
11.13.1 Lineage Cell Therapeutics Company Details
11.13.2 Lineage Cell Therapeutics Business Overview
11.13.3 Lineage Cell Therapeutics Geographic Atrophy Treatment Introduction
11.13.4 Lineage Cell Therapeutics Revenue in Geographic Atrophy Treatment Business (2017-2022)
11.13.5 Lineage Cell Therapeutics Recent Developments
11.14 Allergan
11.14.1 Allergan Company Details
11.14.2 Allergan Business Overview
11.14.3 Allergan Geographic Atrophy Treatment Introduction
11.14.4 Allergan Revenue in Geographic Atrophy Treatment Business (2017-2022)
11.14.5 Allergan Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Geographic Atrophy Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Late-stage (Phase III) Treatment
Table 3. Key Players of Phase II Treatment
Table 4. Key Players of Phase I Treatment
Table 5. Key Players of Pre-Clinical Stage Treatment
Table 6. Global Geographic Atrophy Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Geographic Atrophy Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Geographic Atrophy Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Geographic Atrophy Treatment Market Share by Region (2017-2022)
Table 10. Global Geographic Atrophy Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Geographic Atrophy Treatment Market Share by Region (2023-2028)
Table 12. Geographic Atrophy Treatment Market Trends
Table 13. Geographic Atrophy Treatment Market Drivers
Table 14. Geographic Atrophy Treatment Market Challenges
Table 15. Geographic Atrophy Treatment Market Restraints
Table 16. Global Geographic Atrophy Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Geographic Atrophy Treatment Revenue Share by Players (2017-2022)
Table 18. Global Top Geographic Atrophy Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Geographic Atrophy Treatment as of 2021)
Table 19. Ranking of Global Top Geographic Atrophy Treatment Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Geographic Atrophy Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Geographic Atrophy Treatment Product Solution and Service
Table 23. Date of Enter into Geographic Atrophy Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Geographic Atrophy Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Geographic Atrophy Treatment Revenue Market Share by Type (2017-2022)
Table 27. Global Geographic Atrophy Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Geographic Atrophy Treatment Revenue Market Share by Type (2023-2028)
Table 29. Global Geographic Atrophy Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Geographic Atrophy Treatment Revenue Share by Application (2017-2022)
Table 31. Global Geographic Atrophy Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Geographic Atrophy Treatment Revenue Share by Application (2023-2028)
Table 33. North America Geographic Atrophy Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Geographic Atrophy Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Geographic Atrophy Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Geographic Atrophy Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Geographic Atrophy Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Geographic Atrophy Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Geographic Atrophy Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Geographic Atrophy Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Geographic Atrophy Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Geographic Atrophy Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Geographic Atrophy Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Geographic Atrophy Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Geographic Atrophy Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Geographic Atrophy Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Geographic Atrophy Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Geographic Atrophy Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Geographic Atrophy Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Geographic Atrophy Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Geographic Atrophy Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Geographic Atrophy Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Geographic Atrophy Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Geographic Atrophy Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Geographic Atrophy Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Geographic Atrophy Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Geographic Atrophy Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Geographic Atrophy Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Geographic Atrophy Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Geographic Atrophy Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Geographic Atrophy Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Geographic Atrophy Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 63. Apellis Pharmaceuticals Company Details
Table 64. Apellis Pharmaceuticals Business Overview
Table 65. Apellis Pharmaceuticals Geographic Atrophy Treatment Product
Table 66. Apellis Pharmaceuticals Revenue in Geographic Atrophy Treatment Business (2017-2022) & (US$ Million)
Table 67. Apellis Pharmaceuticals Recent Developments
Table 68. IVERIC bio Company Details
Table 69. IVERIC bio Business Overview
Table 70. IVERIC bio Geographic Atrophy Treatment Product
Table 71. IVERIC bio Revenue in Geographic Atrophy Treatment Business (2017-2022) & (US$ Million)
Table 72. IVERIC bio Recent Developments
Table 73. Alkeus Pharmaceuticals Company Details
Table 74. Alkeus Pharmaceuticals Business Overview
Table 75. Alkeus Pharmaceuticals Geographic Atrophy Treatment Product
Table 76. Alkeus Pharmaceuticals Revenue in Geographic Atrophy Treatment Business (2017-2022) & (US$ Million)
Table 77. Alkeus Pharmaceuticals Recent Developments
Table 78. Hemera Biosciences Company Details
Table 79. Hemera Biosciences Business Overview
Table 80. Hemera Biosciences Geographic Atrophy Treatment Product
Table 81. Hemera Biosciences Revenue in Geographic Atrophy Treatment Business (2017-2022) & (US$ Million)
Table 82. Hemera Biosciences Recent Developments
Table 83. Allegro Ophthalmics Company Details
Table 84. Allegro Ophthalmics Business Overview
Table 85. Allegro Ophthalmics Geographic Atrophy Treatment Product
Table 86. Allegro Ophthalmics Revenue in Geographic Atrophy Treatment Business (2017-2022) & (US$ Million)
Table 87. Allegro Ophthalmics Recent Developments
Table 88. Stealth BioTherapeutics Company Details
Table 89. Stealth BioTherapeutics Business Overview
Table 90. Stealth BioTherapeutics Geographic Atrophy Treatment Product
Table 91. Stealth BioTherapeutics Revenue in Geographic Atrophy Treatment Business (2017-2022) & (US$ Million)
Table 92. Stealth BioTherapeutics Recent Developments
Table 93. Gyroscope Therapeutics Company Details
Table 94. Gyroscope Therapeutics Business Overview
Table 95. Gyroscope Therapeutics Geographic Atrophy Treatment Product
Table 96. Gyroscope Therapeutics Revenue in Geographic Atrophy Treatment Business (2017-2022) & (US$ Million)
Table 97. Gyroscope Therapeutics Recent Developments
Table 98. Regenerative Patch Technologies Company Details
Table 99. Regenerative Patch Technologies Business Overview
Table 100. Regenerative Patch Technologies Geographic Atrophy Treatment Product
Table 101. Regenerative Patch Technologies Revenue in Geographic Atrophy Treatment Business (2017-2022) & (US$ Million)
Table 102. Regenerative Patch Technologies Recent Developments
Table 103. Roche Holding AG Company Details
Table 104. Roche Holding AG Business Overview
Table 105. Roche Holding AG Geographic Atrophy Treatment Product
Table 106. Roche Holding AG Revenue in Geographic Atrophy Treatment Business (2017-2022) & (US$ Million)
Table 107. Roche Holding AG Recent Developments
Table 108. Gensight Biologics SA Company Details
Table 109. Gensight Biologics SA Business Overview
Table 110. Gensight Biologics SA Geographic Atrophy Treatment Product
Table 111. Gensight Biologics SA Revenue in Geographic Atrophy Treatment Business (2017-2022) & (US$ Million)
Table 112. Gensight Biologics SA Recent Developments
Table 113. NGM Biopharmaceuticals Company Details
Table 114. NGM Biopharmaceuticals Business Overview
Table 115. NGM Biopharmaceuticals Geographic Atrophy Treatment Product
Table 116. NGM Biopharmaceuticals Revenue in Geographic Atrophy Treatment Business (2017-2022) & (US$ Million)
Table 117. NGM Biopharmaceuticals Recent Developments
Table 118. AstraZeneca Company Details
Table 119. AstraZeneca Business Overview
Table 120. AstraZeneca Geographic Atrophy Treatment Product
Table 121. AstraZeneca Revenue in Geographic Atrophy Treatment Business (2017-2022) & (US$ Million)
Table 122. AstraZeneca Recent Developments
Table 123. Lineage Cell Therapeutics Company Details
Table 124. Lineage Cell Therapeutics Business Overview
Table 125. Lineage Cell Therapeutics Geographic Atrophy Treatment Product
Table 126. Lineage Cell Therapeutics Revenue in Geographic Atrophy Treatment Business (2017-2022) & (US$ Million)
Table 127. Lineage Cell Therapeutics Recent Developments
Table 128. Allergan Company Details
Table 129. Allergan Business Overview
Table 130. Allergan Geographic Atrophy Treatment Product
Table 131. Allergan Revenue in Geographic Atrophy Treatment Business (2017-2022) & (US$ Million)
Table 132. Allergan Recent Developments
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Geographic Atrophy Treatment Market Share by Type: 2021 VS 2028
Figure 2. Late-stage (Phase III) Treatment Features
Figure 3. Phase II Treatment Features
Figure 4. Phase I Treatment Features
Figure 5. Pre-Clinical Stage Treatment Features
Figure 6. Global Geographic Atrophy Treatment Market Share by Application: 2021 VS 2028
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Geographic Atrophy Treatment Report Years Considered
Figure 10. Global Geographic Atrophy Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Geographic Atrophy Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Geographic Atrophy Treatment Market Share by Region: 2021 VS 2028
Figure 13. Global Geographic Atrophy Treatment Market Share by Players in 2021
Figure 14. Global Top Geographic Atrophy Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Geographic Atrophy Treatment as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Geographic Atrophy Treatment Revenue in 2021
Figure 16. North America Geographic Atrophy Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 17. North America Geographic Atrophy Treatment Market Size Market Share by Type (2017-2028)
Figure 18. North America Geographic Atrophy Treatment Market Size Market Share by Application (2017-2028)
Figure 19. North America Geographic Atrophy Treatment Market Size Share by Country (2017-2028)
Figure 20. United States Geographic Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Geographic Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Geographic Atrophy Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 23. Europe Geographic Atrophy Treatment Market Size Market Share by Type (2017-2028)
Figure 24. Europe Geographic Atrophy Treatment Market Size Market Share by Application (2017-2028)
Figure 25. Europe Geographic Atrophy Treatment Market Size Share by Country (2017-2028)
Figure 26. Germany Geographic Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Geographic Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Geographic Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Geographic Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Geographic Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Geographic Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Geographic Atrophy Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Geographic Atrophy Treatment Market Size Market Share by Type (2017-2028)
Figure 34. Asia Pacific Geographic Atrophy Treatment Market Size Market Share by Application (2017-2028)
Figure 35. Asia Pacific Geographic Atrophy Treatment Market Size Share by Region (2017-2028)
Figure 36. China Geographic Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan Geographic Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea Geographic Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia Geographic Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India Geographic Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia Geographic Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 42. Latin America Geographic Atrophy Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 43. Latin America Geographic Atrophy Treatment Market Size Market Share by Type (2017-2028)
Figure 44. Latin America Geographic Atrophy Treatment Market Size Market Share by Application (2017-2028)
Figure 45. Latin America Geographic Atrophy Treatment Market Size Share by Country (2017-2028)
Figure 46. Mexico Geographic Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Brazil Geographic Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa Geographic Atrophy Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Middle East and Africa Geographic Atrophy Treatment Market Size Market Share by Type (2017-2028)
Figure 50. Middle East and Africa Geographic Atrophy Treatment Market Size Market Share by Application (2017-2028)
Figure 51. Middle East and Africa Geographic Atrophy Treatment Market Size Share by Country (2017-2028)
Figure 52. Turkey Geographic Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Geographic Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. UAE Geographic Atrophy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Apellis Pharmaceuticals Revenue Growth Rate in Geographic Atrophy Treatment Business (2017-2022)
Figure 56. IVERIC bio Revenue Growth Rate in Geographic Atrophy Treatment Business (2017-2022)
Figure 57. Alkeus Pharmaceuticals Revenue Growth Rate in Geographic Atrophy Treatment Business (2017-2022)
Figure 58. Hemera Biosciences Revenue Growth Rate in Geographic Atrophy Treatment Business (2017-2022)
Figure 59. Allegro Ophthalmics Revenue Growth Rate in Geographic Atrophy Treatment Business (2017-2022)
Figure 60. Stealth BioTherapeutics Revenue Growth Rate in Geographic Atrophy Treatment Business (2017-2022)
Figure 61. Gyroscope Therapeutics Revenue Growth Rate in Geographic Atrophy Treatment Business (2017-2022)
Figure 62. Regenerative Patch Technologies Revenue Growth Rate in Geographic Atrophy Treatment Business (2017-2022)
Figure 63. Roche Holding AG Revenue Growth Rate in Geographic Atrophy Treatment Business (2017-2022)
Figure 64. Gensight Biologics SA Revenue Growth Rate in Geographic Atrophy Treatment Business (2017-2022)
Figure 65. NGM Biopharmaceuticals Revenue Growth Rate in Geographic Atrophy Treatment Business (2017-2022)
Figure 66. AstraZeneca Revenue Growth Rate in Geographic Atrophy Treatment Business (2017-2022)
Figure 67. Lineage Cell Therapeutics Revenue Growth Rate in Geographic Atrophy Treatment Business (2017-2022)
Figure 68. Allergan Revenue Growth Rate in Geographic Atrophy Treatment Business (2017-2022)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

以下、関連資料のご紹介

脳がん治療のグローバル市場インサイト・予測（～2028年）

Global Brain Cancer Treatment Market Insights, Forecast to 2028
QY2207C3466 2022年7月11日 109Pages
新型コロナウイルス感染症のパンデミックにより、世界の脳がん治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に脳がん治療の世界市場のxx...

眼がん治療のグローバル市場インサイト・予測（～2028年）

Global Eye Cancer Treatment Market Insights, Forecast to 2028
QY2207C3457 2022年7月11日 113Pages
新型コロナウイルス感染症のパンデミックにより、世界の眼がん治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に眼がん治療の世界市場のxx...

カタレプシー治療のグローバル市場インサイト・予測（～2028年）

Global Catalepsy Treatment Market Insights, Forecast to 2028
QY2207C3470 2022年7月11日 125Pages
新型コロナウイルス感染症のパンデミックにより、世界のカタレプシー治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にカタレプシー治療の世...

移植片対宿主病治療のグローバル市場インサイト・予測（～2028年）

Global Graft Versus Host Disease Treatment Market Insights, Forecast to 2028
QY2207C3465 2022年7月11日 115Pages
新型コロナウイルス感染症のパンデミックにより、世界の移植片対宿主病治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に移植片対宿主病治療...

ファンコニ貧血治療のグローバル市場インサイト・予測（～2028年）

Global Fanconi Anemia Treatment Market Insights, Forecast to 2028
QY2207C3459 2022年7月11日 125Pages
新型コロナウイルス感染症のパンデミックにより、世界のファンコニ貧血治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にファンコニ貧血治療...

眼がん治療のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Eye Cancer Treatment Market The global Eye Cancer Treatment market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028. Fully considering the economic change by this health crisis, Oral accounting for % of the…
脳がん治療のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Brain Cancer Treatment Market The global Brain Cancer Treatment market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028. Fully considering the economic change by this health crisis, Chemotherapy accounting …
ファンコニ貧血治療のグローバル市場インサイト・予測（～2028年） Fanconi anemia is an autosomal recessive illness marked by impaired haemopoiesis, congenital anomalies, and a significant incidence of solid tumors and acute myeloid leukaemia in patients. It is a rare disease that affects the bone marrow and is handed down via families (inherited). Fanconi anemia i…
カタレプシー治療のグローバル市場インサイト・予測（～2028年） A state of marked loss of voluntary mobility in which the limbs remain in whatever posture they are placed is known as catalepsy. Voluntary motion loss, muscle rigidity, fixed posture, and diminished pain sensitivity are all symptoms of catalepsy. It can be a sign of a variety of diseases, including…
移植片対宿主病治療のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Graft Versus Host Disease Treatment Market The global Graft Versus Host Disease Treatment market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028. Fully considering the economic change by this health crisis…